Boardroom Alpha
Meeting calendar
CVEO · Annual meeting · Wednesday, May 27, 2026

Civeo Corp

6 nominees · 4 ballot items.

Elect six directors (Class II and III) to one-year terms; approve, on an advisory basis, executive compensation (Say-on-Pay); approve an amendment to the 2014 Equity Participation Plan to increase the share reserve by 520,920 shares; and ratify Ernst & Young LLP as independent auditors for 2026 and authorize Audit Committee to set their remuneration.

Market cap
$383M
1Y TSR
+36.3%
Board grade
B-
Record date
Mar 30, 2026
Filing
DEF 14A
Meeting concluded · May 27, 2026

Follow how the vote landed and what changed on Civeo Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect six persons—Bradley J. Dodson, Martin A. Lambert, Constance B. Moore, Richard A. Navarre, Daniel B. Silvers and Timothy O. Wall—as Class II and Class III directors for one-year terms ending at the 2027 annual general meeting.

  2. 2

    Advisory Vote to Approve Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of Civeo’s named executive officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis and compensation tables.

    More detail

    This management-sponsored advisory (Say-on-Pay) proposal asks shareholders to approve the company’s disclosed compensation for its named executive officers, as described in the Compensation Discussion and Analysis and accompanying tables. Management frames executive pay around a structured mix of base salary, an Annual Incentive Compensation Plan (AICP) tied to consolidated and divisional AICP EBITDA and safety (TRIR), and a long-term incentive program under the EPP largely composed of performance share awards and phantom share units. The Compensation Committee uses independent consultant Mercer benchmarking and retains discretion to set targets, adjustments and payouts; the committee capped performance payouts and applies clawback and share ownership policies to mitigate risk. Management highlights strong shareholder engagement (meetings representing over 52% of shares) and high prior-year Say-on-Pay support (95.7% in 2025) as context for continuing the current approach. The vote is non-binding; however, the Compensation Committee will review results and consider shareholder feedback in future design choices. Key governance features include performance metrics (relative TSR and three-year EBITDA growth), caps to limit excessive payouts (including a 100% cap on relative TSR component if absolute TSR is negative), double-trigger change-of-control protections, and a clawback policy for accounting restatements. The board recommends a FOR vote because it believes the program aligns management and shareholder interests, balances short- and long-term incentives, and includes safeguards against excessive risk-taking and poor alignment. From an investor perspective, the program’s linkage to multi-year EBITDA growth and relative TSR provides alignment but investors should note the Compensation Committee’s discretion to adjust metrics and AICP adjustments for unbudgeted items, which may affect payout outcomes. Overall, the proposal represents a routine advisory request that informs but does not bind the board’s compensation decisions.

  3. 3

    Approval of an Amendment to the 2014 Equity Participation Plan (EPP

    ManagementBoard: FOR

    Approve an amendment to the 2014 Equity Participation Plan to increase the number of shares available for issuance under the EPP by 520,920 shares (subject to adjustment under the EPP) and extend certain plan provisions.

    More detail

    This management proposal seeks shareholder approval to amend Civeo’s 2014 Equity Participation Plan by increasing the share reserve by 520,920 shares and extending the outside date for granting incentive stock options; the board contends the increase is needed to support future long-term incentive grants to employees, executives and non-employee directors. Management explains the share request was determined after reviewing remaining availability under the EPP, projected grant usage, and input from an independent proxy advisor and Mercer, the compensation consultant; if approved, total shares available would increase from 865,883 to 1,386,803. The amendment includes governance features intended to limit dilution and poor practices: no repricing without shareholder approval, no discounted options, ten-year option terms, minimum vesting (one year for 95% of reserve), restrictions on liberal share recycling, an annual director award cap ($500,000), clawback applicability, and no evergreen provision—so future replenishment requires shareholder approval. Management quantifies potential dilution at approximately 4.76% from the additional 520,920 shares versus outstanding shares as of March 30, 2026 and indicates total potential dilution under the plan would be about 12.67% if the amendment is approved, which investors should assess relative to peer practices and historical burn rates. The Compensation Committee will administer the Amended EPP and may delegate grants to the CEO for non-Section 16 participants subject to constraints; individual award limits are set to cap large single-year grants. The board recommends a FOR vote, arguing that the program is critical for retention and alignment of long-term incentives with shareholder value, while including features intended to protect shareholders from abuse or excessive dilution. From an analytical view, the proposal is routine for companies issuing equity incentives but merits investor scrutiny of projected grant pacing, historical dilution, and whether current equity grants have produced measurable TSR or operating improvements; the inclusion of minimum vesting, anti-repricing protections and explicit caps is positive governance context.

  4. 4

    Ratification of Ernst & Young LLP as Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the appointment of Ernst & Young LLP as Civeo’s independent registered public accounting firm for the year ending December 31, 2026 and authorize the Audit Committee to determine their remuneration.

Director elections

Nominees on the ballot6

Independent
Tenure on this board
11.5 yrs
Also a director at
Healthcare Realty Trust Inc (HR)
Independent
Tenure on this board
12.2 yrs
Also a director at
Natural Resource Partners LP (NRP)Core Natural Resources Inc (CNR)
Ownership

Top institutional holders10

Latest 13F quarter
1HORIZON KINETICS ASSET MANAGEMENT LLC21.5%2,352,353$62M
2Engine Capital Management, LPActivist8.0%874,476$23M
3TCW GROUP INC7.7%846,645$22M
4DIMENSIONAL FUND ADVISORS LP5.5%603,282$16M
5AMERICAN CENTURY COMPANIES INC5.1%561,834$15M
6RENAISSANCE TECHNOLOGIES LLC4.6%501,732$13M
7Flat Footed LLC3.2%347,240$9M
8PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.2.8%306,334$8M
9GOLDMAN SACHS GROUP INC1.8%200,181$5M
10JB CAPITAL PARTNERS LP1.8%193,750$5M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Civeo Corp 2026 annual meeting?
Civeo Corp (CVEO) holds its 2026 annual shareholder meeting on Wednesday, May 27, 2026.
What is the record date for the Civeo Corp 2026 meeting?
The record date for the Civeo Corp 2026 meeting is Monday, March 30, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Civeo Corp's 2026 meeting?
The board is presenting 6 director nominees at the Civeo Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Civeo Corp 2026 meeting?
Shareholders will vote on 4 proposals at the Civeo Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer